[ad_1] Reviewed by Emily Henderson, B.Sc.November 11, 2020 Purdue University scientists are developing a new treatment option for pulmonary fibrosis. Pulmonary fibrosis has been a concern for COVID-19 patients. People with idiopathic pulmonary fibrosis (IPF) have a life expectancy of less than five years. Fibrotic diseases cause organ failure that …
Read More »Scientists are developing a new treatment option for pulmonary fibrosis
